EU Life Sciences Regulatory Forecast to 2027

Life Sciences Webinar

November 2, 2026 | 10:00 AM ET

As the end of 2026 fast approaches, European regulators are busy wrapping up several initiatives ranging from clinical trials to postmarket device surveillance. Policymakers are also trying to adopt key legislation, such as the pharmaceutical package and the Critical Medicines Act, while simultaneously aligning their positions on pending legislation, including Biotech Act I and the targeted amendments to the Medical Device and In Vitro Diagnostic regulations.

In this webinar, AgencyIQ EU experts highlight major accomplishments and work/priorities that will carry over into 2027 – including the search for the new executive director.